Regulation for nuclear targeting of the Abl tyrosine kinase in response to DNA damage
- PMID: 17695727
- DOI: 10.1007/978-0-387-69116-9_15
Regulation for nuclear targeting of the Abl tyrosine kinase in response to DNA damage
Abstract
Abl is a ubiquitously expressed nonreceptor tyrosine kinase that is involved in diverse cellular signaling cascades. The cellular response mediated by Abl depends upon its subcellular localization. Expression of Abl in the cytoplasm results in cell proliferation and survival. In contrast, nuclear Abl is activated and induces apoptosis after genotoxic stress. Recent studies have demonstrated the molecular mechanisms by which c-Abl moves into the nucleus in the response to DNA damage. In normal cells, 14-3-3 proteins sequester c-Abl in the cytosol. Upon exposure of cells to genotoxic agents, c-jun N-terminal kinase is activated and phosphorylates 14-3-3, resulting in the release of c-Abl into the nucleus. Moreover, nuclear targeting of c-Abl is required for the induction of apoptosis in response to DNA-damaging agents. Thus, c-Abl may determine cell fate via its subcellular localization. This review summarizes the implications of these findings on our understanding of Abl-regulated cellular functions and potential therapeutic strategies to modulate the aberrant kinase.
Similar articles
-
Enabling death by the Abl tyrosine kinase: mechanisms for nuclear shuttling of c-Abl in response to DNA damage.Cell Cycle. 2005 Jun;4(6):777-9. doi: 10.4161/cc.4.6.1746. Epub 2005 Jun 14. Cell Cycle. 2005. PMID: 15917667
-
JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage.Nat Cell Biol. 2005 Mar;7(3):278-85. doi: 10.1038/ncb1228. Nat Cell Biol. 2005. PMID: 15696159
-
Determination of cell fate by c-Abl activation in the response to DNA damage.Oncogene. 1998 Dec 24;17(25):3309-18. doi: 10.1038/sj.onc.1202571. Oncogene. 1998. PMID: 9916993 Review.
-
MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage.EMBO J. 2006 Aug 23;25(16):3774-83. doi: 10.1038/sj.emboj.7601263. Epub 2006 Aug 3. EMBO J. 2006. PMID: 16888623 Free PMC article.
-
Nuclear trafficking of pro-apoptotic kinases in response to DNA damage.Trends Mol Med. 2008 Jul;14(7):305-13. doi: 10.1016/j.molmed.2008.05.003. Epub 2008 Jun 6. Trends Mol Med. 2008. PMID: 18539531 Review.
Cited by
-
c-Abl Inhibitors in Parkinson's: Exploring Hypotheses on Alpha-Synuclein Modulation.Adv Pharm Bull. 2025 Feb 9;15(1):7-10. doi: 10.34172/apb.42806. eCollection 2025 Apr. Adv Pharm Bull. 2025. PMID: 40636304 Free PMC article.
-
Doxorubicin bypasses the cytoprotective effects of eIF2α phosphorylation and promotes PKR-mediated cell death.Cell Death Differ. 2011 Jan;18(1):145-54. doi: 10.1038/cdd.2010.76. Epub 2010 Jun 18. Cell Death Differ. 2011. PMID: 20559319 Free PMC article.
-
Regulation of neuronal cell death by c-Abl-Hippo/MST2 signaling pathway.PLoS One. 2012;7(5):e36562. doi: 10.1371/journal.pone.0036562. Epub 2012 May 9. PLoS One. 2012. PMID: 22590567 Free PMC article.
-
Proteomics and pathway analysis identifies JNK signaling as critical for high linear energy transfer radiation-induced apoptosis in non-small lung cancer cells.Mol Cell Proteomics. 2009 May;8(5):1117-29. doi: 10.1074/mcp.M800274-MCP200. Epub 2009 Jan 23. Mol Cell Proteomics. 2009. PMID: 19168796 Free PMC article.
-
c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease.Hum Mol Genet. 2014 Jun 1;23(11):2858-79. doi: 10.1093/hmg/ddt674. Epub 2014 Jan 9. Hum Mol Genet. 2014. PMID: 24412932 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous